Volume 22, Issue S1 pp. 86-89
Invited Review

Are PR3 positive and MPO positive GPA the same disease?

Sarah Fordham

Sarah Fordham

Department of Rheumatology, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK

Search for more papers by this author
Chetan Mukhtyar

Corresponding Author

Chetan Mukhtyar

Department of Rheumatology, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK

Correspondence: Chetan Mukhtyar, Consultant Rheumatologist, Department of Rheumatology, Norfolk and Norwich University Hospitals NHS Foundation Trust, Colney Lane, Norwich, NR4 7UY, UK. Email: [email protected]Search for more papers by this author
First published: 03 April 2018
Citations: 4

Abstract

Granulomatosis with Polyangiitis is a necrotising systemic vasculitis predominantly affecting small and medium sized vessels. It is predominantly associated with antibodies directed against proteinase 3, but a small number of individuals with this disease have antibodies directed against myeloperoxidase. The premise of this paper is to explore the possibility that these two serotypes maybe two separate diseases. There is evidence that the same single nucleotide polymorphisms in the TLR 9 gene is associated with increased risk for PR3 ANCA positivity but protects against MPO ANCA positivity. There is some evidence that MPO ANCA positive GPA disease may be ‘limited’ in its expression and be associated with the more indolent phenotype. The genotype may affect the serotype, and the serotype might affect the phenotype. There has been limited success in identifying how the difference in phenotype might affect outcomes. We are at a very early stage in our understanding of how these serotypes might be treated differently. This paper attempts to critically appraise the evidence available so far.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.